Placenta
Volume 29, Issue 11 , Pages 970-975 , November 2008

Nuclear Localisation of the Endocannabinoid Metabolizing Enzyme Fatty Acid Amide Hydrolase (FAAH) in Invasive Trophoblasts and an Association with Recurrent Miscarriage

  • L.W. Chamley

      Affiliations

    • Department of Obstetrics and Gynaecology, University of Auckland, Auckland, New Zealand
    • Fertility Plus, Auckland District Health Board, Auckland, New Zealand
    • Corresponding Author InformationCorresponding author. Department of Obstetrics and Gynaecology, University of Auckland, Private Bag, 92019 Auckland, New Zealand.
    • ,
  • A. Bhalla

      Affiliations

    • Department of Obstetrics and Gynaecology, University of Auckland, Auckland, New Zealand
    • ,
  • P.R. Stone

      Affiliations

    • Department of Obstetrics and Gynaecology, University of Auckland, Auckland, New Zealand
    • ,
  • H. Liddell

      Affiliations

    • Recurrent Miscarriages Clinic, National Women's Hospital, Auckland District Health Board, Auckland, New Zealand
    • ,
  • S. O'Carroll

      Affiliations

    • Department of Anatomy, University of Auckland, Auckland, New Zealand
    • ,
  • C. Kearn

      Affiliations

    • Department of Anesthesiology, University of Washington, Seattle, WA, USA
    • ,
  • M. Glass

      Affiliations

    • Department of Pharmacology, University of Auckland, Auckland, New Zealand

,Accepted 6 August 2008.

References 

  1. Rai R, Regan L. Recurrent miscarriage. Lancet. 2006;368:601–611
  2. Stirrat GM. Recurrent miscarriage. II: clinical associations, causes, and management. Lancet. 1990;336:728–733
  3. Stirrat GM. Recurrent miscarriage. Lancet. 1990;336:673–675
  4. Farquharson RG, Jauniaux E, Exalto N. Updated and revised nomenclature for description of early pregnancy events. Hum Reprod. 2005;20:3008–3011
  5. Jauniaux E, Farquharson RG, Christiansen OB, Exalto N. Evidence-based guidelines for the investigation and medical treatment of recurrent miscarriage. Hum Reprod. 2006;21:2216–2222
  6. Mechoulam R, Gaoni Y. The absolute configuration of delta-1-tetrahydrocannabinol, the major active constituent of hashish. Tetrahedron Lett. 1967;12:1109–1111
  7. Helliwell RA, Chamley LW, Blake-Palmer K, Mitchell MD, Wu J, Kearn CS, et al. Characterisation of the endocannabinoid system in early human pregnancy. J Clin Endocrinol Metab. 2004;89:5168–5174
  8. Habayeb OM, Taylor AH, Bell SC, Taylor DJ, Konje JC. Expression of the endocannabinoid system in human first trimester placenta and its role in trophoblast proliferation. Endocrinology. 2008;
  9. Maccarrone M, Bisogno T, Valensise H, Lazzarin N, Fezza F, Manna C, et al. Low fatty acid amide hydrolase and high anandamide levels are associated with failure to achieve an ongoing pregnancy after IVF and embryo transfer. Mol Hum Reprod. 2002;8:188–195
  10. Maccarrone M, Falciglia K, Di Rienzo M, Finazzi-Agro A. Endocannabinoids, hormone-cytokine networks and human fertility. Prostaglandins Leukot Essent Fatty Acids. 2002;66:309–317
  11. Wang H, Xie H, Guo Y, Zhang H, Takahashi T, Kingsley PJ, et al. Fatty acid amide hydrolase deficiency limits early pregnancy events. J Clin Invest. 2006;116:2122–2131
  12. Turco MY, Matsukawa K, Czernik M, Gasperi V, Battista N, Della Salda L, et al. High levels of anandamide, an endogenous cannabinoid, block the growth of sheep preimplantation embryos by inducing apoptosis and reversible arrest of cell proliferation. Hum Reprod. 2008;
  13. Maccarrone M, Valensise H, Bari M, Lazzarin N, Romanini C, Finazzi-Agro A. Relation between decreased anandamide hydrolase concentrations in human lymphocytes and miscarriage. Lancet. 2000;355:1326–1329
  14. Khong T, Liddell H, Robertson W. Defective haemochorial placentation as a cause of miscarriage: a preliminary study. Br J Obstet Gynaecol. 1987;94:449–455
  15. Askelund K, Liddell HS, Zanderigo AM, Fernando NS, Khong TY, Stone PR, et al. CD83(+)dendritic cells in the decidua of women with recurrent miscarriage and normal pregnancy. Placenta. 2004;25:140–145
  16. Bhalla A, Stone PR, Liddell HS, Zanderigo A, Chamley LW. Comparison of the expression of human leukocyte antigen (HLA)-G and HLA-E in women with normal pregnancy and those with recurrent miscarriage. Reproduction. 2006;131:583–589
  17. Martelli AM, Gilmour RS, Bertagnolo V, Neri LM, Manzoli L, Cocco L. Nuclear localization and signalling activity of phosphoinositidase C beta in Swiss 3T3 cells. Nature. 1992;358:242–245
  18. Schmid PC, Paria BC, Krebsbach RJ, Schmid HH, Dey SK. Changes in anandamide levels in mouse uterus are associated with uterine receptivity for embryo implantation. Proc Natl Acad Sci U S A. 1997;94:4188–4192
  19. Paria BC, Dey SK. Ligand-receptor signaling with endocannabinoids in preimplantation embryo development and implantation. Chem Phys Lipids. 2000;108:211–220
  20. Paria BC, Das SK, Dey SK. The preimplantation mouse embryo is a target for cannabinoid ligand-receptor signaling. Proc Natl Acad Sci U S A. 1995;92:9460–9464
  21. Paria BC, Ma W, Andrenyak DM, Schmid PC, Schmid HH, Moody DE, et al. Effects of cannabinoids on preimplantation mouse embryo development and implantation are mediated by brain-type cannabinoid receptors. Biol Reprod. 1998;58:1490–1495
  22. Yang ZM, Paria BC, Dey SK. Activation of brain-type cannabinoid receptors interferes with preimplantation mouse embryo development. Biol Reprod. 1996;55:756–761
  23. Liu WM, Duan EK, Cao YJ. Effects of anandamide on embryo implantation in the mouse. Life Sci. 2002;71:1623–1632
  24. Wang J, Paria BC, Dey SK, Armant DR. Stage-specific excitation of cannabinoid receptor exhibits differential effects on mouse embryonic development. Biol Reprod. 1999;60:839–844
  25. Lockwood CJ. Prediction of pregnancy loss. Lancet. 2000;355:1292–1293
  26. Wang H, Dey SK, Maccarrone M. Jekyll and hyde: two faces of cannabinoid signaling in male and female fertility. Endocr Rev. 2006;27:427–448
  27. Wang H, Xie H, Sun X, Kingsley PJ, Marnett LJ, Cravatt BF, et al. Differential regulation of endocannabinoid synthesis and degradation in the uterus during embryo implantation. Prostaglandins Other Lipid Mediat. 2007;83:62–74
  28. Loke YW, King A, Burrows TD. Decidua in human implantation. Hum Reprod. 1995;10(Suppl. 2):14–21
  29. Kessler CA, Moghadam KK, Schroeder JK, Buckley AR, Brar AK, Handwerger S. Cannabinoid receptor I activation markedly inhibits human decidualization. Mol Cell Endocrinol. 2005;229:65–74
  30. Di Marzo V, Bisogno T, De Petrocellis L, Melck D, Orlando P, Wagner JA, et al. Biosynthesis and inactivation of the endocannabinoid 2-arachidonoylglycerol in circulating and tumoral macrophages. Eur J Biochem. 1999;264:258–267
  31. Sun YX, Tsuboi K, Zhao LY, Okamoto Y, Lambert DM, Ueda N. Involvement of N-acylethanolamine-hydrolyzing acid amidase in the degradation of anandamide and other N-acylethanolamines in macrophages. Biochim Biophys Acta. 2005;1736:211–220
  32. Gulyas AI, Cravatt BF, Bracey MH, Dinh TP, Piomelli D, Boscia F, et al. Segregation of two endocannabinoid-hydrolyzing enzymes into pre- and postsynaptic compartments in the rat hippocampus, cerebellum and amygdala. Eur J Neurosci. 2004;20:441–458
  33. Marrache AM, Gobeil F, Zhu T, Chemtob S. Intracellular signaling of lipid mediators via cognate nuclear G protein-coupled receptors. Endothelium. 2005;12:63–72

PII: S0143-4004(08)00240-3

doi: 10.1016/j.placenta.2008.08.003

Placenta
Volume 29, Issue 11 , Pages 970-975 , November 2008

Article Tools

* Image Usage & Resolution